Drug Shortage Report for METHOTREXATE SUBCUTANEOUS
Report ID | 133083 |
Drug Identification Number | 02491362 |
Brand name | METHOTREXATE SUBCUTANEOUS |
Common or Proper name | METHOTREXATE SUBCUTANEOUS |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | Vial |
ATC code | L04AX |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-02-02 |
Estimated end date | |
Actual end date | 2021-02-23 |
Shortage status | Resolved |
Updated date | 2021-02-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-02-24 | French | Compare |
v8 | 2021-02-24 | English | Compare |
v7 | 2021-02-24 | French | Compare |
v6 | 2021-02-24 | English | Compare |
v5 | 2021-02-19 | French | Compare |
v4 | 2021-02-19 | English | Compare |
v3 | 2021-02-03 | English | Compare |
v2 | 2021-02-02 | French | Compare |
v1 | 2021-02-02 | English | Compare |
Showing 1 to 9 of 9